Last reviewed · How we verify
LNG-IUS: levonorgestrel intrauterine system — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
LNG-IUS: levonorgestrel intrauterine system (LNG-IUS: levonorgestrel intrauterine system) — University of Sao Paulo.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| LNG-IUS: levonorgestrel intrauterine system TARGET | LNG-IUS: levonorgestrel intrauterine system | University of Sao Paulo | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- LNG-IUS: levonorgestrel intrauterine system CI watch — RSS
- LNG-IUS: levonorgestrel intrauterine system CI watch — Atom
- LNG-IUS: levonorgestrel intrauterine system CI watch — JSON
- LNG-IUS: levonorgestrel intrauterine system alone — RSS
Cite this brief
Drug Landscape (2026). LNG-IUS: levonorgestrel intrauterine system — Competitive Intelligence Brief. https://druglandscape.com/ci/lng-ius-levonorgestrel-intrauterine-system. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab